
Please try another search
Chosa Oncology AB develops oncology drugs for the treatment of cancer. The company was formerly known as Chosa ApS. Chosa Oncology AB founded in 2022 and is based in Lund, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Ingrid Atteryd Heiman | 66 | 2023 | Board Chair |
Neil Goldsmith | 61 | 2023 | Director |
Morten Myrhoj | 57 | 2024 | Director |
Claus Frisenberg Pedersen | 52 | 2023 | Chief Commercial Officer & Board Member |
Ulla Hald Buhl | 60 | 2023 | COO & Board Member |
Fred R. Hirsch | - | 2024 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review